US Broker Ratings

Royalty Pharma plc (RPRX) Stock Analysis: Harnessing Biopharma Royalties with a 6% Upside Potential

Royalty Pharma plc (NASDAQ: RPRX) stands as a unique player in the biopharmaceutical sector, offering investors a distinctive approach to capitalizing on the healthcare industry’s growth...

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Unpacking the 67% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a key player in the biotechnology sector, continues to capture investor attention with its promising pipeline of therapies targeting rare diseases...

DaVita Inc. (DVA) Stock Analysis: Navigating the Healthcare Sector with Strong Revenue Growth and High ROE

DaVita Inc. (NYSE: DVA) stands as a pivotal player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Denver, Colorado, DaVita specializes..

Waters Corporation (WAT) Stock Analysis: Unlocking a 24.41% Upside Potential for Healthcare Investors

Waters Corporation (NYSE: WAT) stands out in the healthcare sector’s diagnostics and research industry, offering promising opportunities for investors. With a market capitalization of $30.42 billion,..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a Potential 30% Upside in Healthcare Biotech

Roivant Sciences Ltd. (NASDAQ: ROIV) stands as a formidable player in the healthcare sector, particularly within the biotechnology industry. Based in London, the company has a..

Alkermes plc (ALKS) Investor Outlook: Analyzing a 32.80% Upside Potential Amidst a Challenging Year

Alkermes plc (NASDAQ: ALKS) presents an interesting investment opportunity within the healthcare sector, particularly in the drug manufacturing niche focusing on specialty and generic drugs. Headquartered..

DexCom, Inc. (DXCM) Stock Analysis: 41% Potential Upside Drives Investor Interest

DexCom, Inc. (DXCM) is a prominent player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $23.76 billion, this San..

Hologic, Inc. (HOLX) Stock Analysis: Steady Healthcare Innovator with Limited Upside Potential

Hologic, Inc. (NASDAQ: HOLX), a leading player in the medical instruments and supplies industry, is a prominent name in the healthcare sector. With a market capitalization..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Unveiling a 21.71% Upside Potential in the Biotech Space

TG Therapeutics, Inc. (NASDAQ: TGTX), a promising player in the biopharmaceutical landscape, continues to captivate investor interest with its dynamic approach to treating B-cell mediated diseases...

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A Deep Dive into its 37.18% Potential Upside

BridgeBio Pharma, Inc. (NASDAQ: BBIO) presents a compelling opportunity for investors looking to capitalize on the burgeoning biotechnology sector. With a market cap of $14.21 billion,..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 28% Potential Upside in the Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR), a prominent player within the healthcare sector focusing on medical devices, presents an intriguing opportunity for investors seeking substantial growth potential. With..

Viatris Inc. (VTRS) Stock Analysis: Exploring Potential Gains with a 7.76% Upside

Investors eyeing the healthcare sector may find Viatris Inc. (NASDAQ: VTRS) an intriguing prospect, especially with a potential upside of 7.76% based on the current average..

Biogen Inc. (BIIB) Stock Analysis: Exploring a 15% Potential Upside Amidst Evolving Healthcare Dynamics

Biogen Inc. (BIIB), a prominent player in the healthcare sector, primarily operates within the drug manufacturing industry, focusing on developing and delivering therapies for a range..

ICON plc (ICLR) Stock Analysis: Unveiling a 29.27% Potential Upside Amidst a Transformative Era in Clinical Research

ICON plc (NASDAQ: ICLR) stands at the forefront of the healthcare diagnostics and research industry, with a commanding presence in clinical research organization services. Headquartered in..

Globus Medical, Inc. (GMED)

⚠️ No article content returned.

..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a 41.87% Potential Upside

Universal Health Services, Inc. (NYSE: UHS) stands as a formidable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization..

Grifols, S.A. (GRFS) Stock Analysis: Is a 37% Upside Within Reach?

Grifols, S.A. (NASDAQ: GRFS), a significant player in the healthcare sector, primarily operates within the drug manufacturing industry. With a market capitalization of $5.5 billion, the..

Axsome Therapeutics, Inc. (AXSM) Investor Outlook: Unpacking a 20% Potential Upside Amidst Robust CNS Pipeline

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is a prominent player in the biotechnology sector, focusing on the development of novel therapies for central nervous system (CNS) disorders...

Qiagen N.V. (QGEN) Stock Analysis: Exploring a 40% Potential Upside for Investors

Investors looking to dive into the healthcare sector may find Qiagen N.V. (NASDAQ: QGEN) an intriguing opportunity. With a market cap of $7.92 billion, Qiagen stands..

ResMed Inc. (RMD) Stock Analysis: 32.97% Potential Upside Captivates Investors

ResMed Inc. (NYSE: RMD), a stalwart in the healthcare sector, specifically within the medical instruments and supplies industry, is drawing attention from investors with its promising..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds